103 related articles for article (PubMed ID: 10486171)
1. Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible?
Kordower JH; Isacson O; Emerich DF
Exp Neurol; 1999 Sep; 159(1):4-20. PubMed ID: 10486171
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
[TBL] [Abstract][Full Text] [Related]
3. Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible?
Kordower JH; Isacson O; Leventhal L; Emerich DF
Prog Brain Res; 2000; 127():414-30. PubMed ID: 11142039
[No Abstract] [Full Text] [Related]
4. Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6/1 mice.
Denovan-Wright EM; Attis M; Rodriguez-Lebron E; Mandel RJ
J Neurosci Res; 2008 Jun; 86(8):1748-57. PubMed ID: 18293418
[TBL] [Abstract][Full Text] [Related]
5. Cellular delivery of CNTF but not NT-4/5 prevents degeneration of striatal neurons in a rodent model of Huntington's disease.
Emerich DF; Bruhn S; Chu Y; Kordower JH
Cell Transplant; 1998; 7(2):213-25. PubMed ID: 9588602
[TBL] [Abstract][Full Text] [Related]
6. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH
Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076
[TBL] [Abstract][Full Text] [Related]
7. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
[TBL] [Abstract][Full Text] [Related]
8. [Nerve growth factor: possibilities and limitations of its clinical application].
Castellanos-Ortega MR; Cruz-Aguado R; Martínez-Martí L
Rev Neurol; 1999 Sep 1-15; 29(5):439-47. PubMed ID: 10584248
[TBL] [Abstract][Full Text] [Related]
9. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice.
Hermann DM; Kilic E; Kügler S; Isenmann S; Bähr M
Neurobiol Dis; 2001 Aug; 8(4):655-66. PubMed ID: 11493030
[TBL] [Abstract][Full Text] [Related]
11. Intracerebral implantation of NGF-releasing biodegradable microspheres protects striatum against excitotoxic damage.
Menei P; Pean JM; Nerrière-Daguin V; Jollivet C; Brachet P; Benoit JP
Exp Neurol; 2000 Jan; 161(1):259-72. PubMed ID: 10683292
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease.
de Almeida LP; Zala D; Aebischer P; Déglon N
Neurobiol Dis; 2001 Jun; 8(3):433-46. PubMed ID: 11442352
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells.
Pineda JR; Rubio N; Akerud P; Urbán N; Badimon L; Arenas E; Alberch J; Blanco J; Canals JM
Gene Ther; 2007 Jan; 14(2):118-28. PubMed ID: 16943855
[TBL] [Abstract][Full Text] [Related]
14. In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease.
Kordower JH
Ann Neurol; 2003; 53 Suppl 3():S120-32; discussion S132-4. PubMed ID: 12666104
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes.
Popovic N; Maingay M; Kirik D; Brundin P
Exp Neurol; 2005 May; 193(1):65-74. PubMed ID: 15817265
[TBL] [Abstract][Full Text] [Related]
17. Disease Modification Through Trophic Factor Delivery.
Savolainen M; Emerich D; Kordower JH
Methods Mol Biol; 2018; 1780():525-547. PubMed ID: 29856034
[TBL] [Abstract][Full Text] [Related]
18. Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease.
Popoli P; Blum D; Martire A; Ledent C; Ceruti S; Abbracchio MP
Prog Neurobiol; 2007 Apr; 81(5-6):331-48. PubMed ID: 17303312
[TBL] [Abstract][Full Text] [Related]
19. Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease.
Ryu JK; Kim J; Cho SJ; Hatori K; Nagai A; Choi HB; Lee MC; McLarnon JG; Kim SU
Neurobiol Dis; 2004 Jun; 16(1):68-77. PubMed ID: 15207263
[TBL] [Abstract][Full Text] [Related]
20. Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.
Mittoux V; Ouary S; Monville C; Lisovoski F; Poyot T; Conde F; Escartin C; Robichon R; Brouillet E; Peschanski M; Hantraye P
J Neurosci; 2002 Jun; 22(11):4478-86. PubMed ID: 12040055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
